Related Experiment Videos
Glucagonoma syndrome: a case report.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|September 30, 1999
Summary
Glucagonoma, a rare pancreatic tumor, often presents with necrolytic migratory erythema and diabetes mellitus. Surgical removal of the tumor can resolve these glucagonoma syndrome symptoms.
Area of Science:
- Endocrinology
- Surgical Oncology
- Dermatology
Background:
- Glucagonoma is an exceptionally rare neuroendocrine tumor originating from pancreatic alpha cells.
- It is characterized by the overproduction of glucagon, leading to a distinct clinical syndrome.
Observation:
- A case study details a pancreatic tail tumor presenting with classic glucagonoma syndrome: necrolytic migratory erythema (NME), diabetes mellitus (DM), anemia, weight loss, and glossitis.
- Surgical resection of the pancreatic tumor resulted in the complete resolution of the glucagonoma syndrome.
Findings:
- A literature review of 120 glucagonoma cases revealed an average tumor diameter of 3.6 cm, with 68.1% located in the pancreatic tail.
- Two-thirds of glucagonomas were malignant, and 53.5% had metastasized. The curative resection rate was 45.8%.
Implications:
- The diagnosis of glucagonoma should be strongly suspected in patients presenting with the triad of a pancreatic tumor, NME, and DM.
- Early diagnosis and surgical intervention are crucial for improving patient outcomes in glucagonoma cases.